Clinical Trials Browser

Phase 2 × OTHER_GOV × Carcinoma, Hepatocellular × Clear all

NCT07128251 2025-08-17

A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)

Phase 2 Not yet recruiting

Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Carcinoma, Hepatocellular

NCT06685354 2024-11-12

Sequential T and I With H101 Via HAI for BCLC C Stage HCC: A Prospective Single-Center Single-Arm Pilot Study

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT06498622 2024-07-12

Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05897138 2023-06-13

A Study to Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker Analyses

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05407519 2023-03-22

A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

Phase 2 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05545124 2022-09-19

Study of Donafenib Combined With Tislelizumab in the Adjuvant Treatment of Primary HCC With High Risk of Recurrence

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT00919009 2012-05-30

Combination of Transcatheter Arterial Chemoembolization (TACE) and Sorafenib for Patients With Unresectable Hepatocellular Carcinoma (HCC)

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT01377220 2011-06-21

CHOLPET

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT00990860 2011-01-05

START

Phase 2 Unknown

Gastrointestinal

Carcinoma, Hepatocellular